Mutation profile and immunoscore signature in thymic carcinomas: An exploratory study and review of the literature-Reference-Cited by-同舟云学术

Mutation profile and immunoscore signature in thymic carcinomas: An exploratory study and review of the literature

Published:2021-03-11 Issue:9 Volume:12 Page:1271-1278
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Asselta Rosanna¹²,Di Tommaso Luca¹³,Perrino Matteo⁴,Destro Annarita³,Giordano Laura⁵,Cardamone Giulia¹,Rubino Luca⁴,Santoro Armando¹⁴^ORCID,Duga Stefano¹²,Zucali Paolo Andrea¹⁴

Affiliation:

1. Department of Biomedical Sciences Humanitas University Milan Italy

2. Humanitas Clinical and Research Center IRCCS Milan Italy

3. Unit of Pathology IRCCS, Humanitas Clinical and Research Center Milan Italy

4. Department of Oncology IRCCS, Humanitas Clinical and Research Center Milan Italy

5. Statistic Unit IRCCS, Humanitas Clinical and Research Center Milan Italy

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13765

Reference34 articles.

1. Malignant thymoma in the United States: Demographic patterns in incidence and associations with subsequent malignancies

2. Thymoma and thymic carcinomas

3. Molecular Pathology of Thymic Epithelial Neoplasms

4. A Gene Signature to Determine Metastatic Behavior in Thymomas

5. Comprehensive Genomic Analysis Reveals Clinically Relevant Molecular Distinctions between Thymic Carcinomas and Thymomas

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Depiction of the Genetic Alterations and Molecular Landscapes of Thymic Epithelial Tumors: A Systematic Review and Meta-Analysis;Cancers;2024-08-25

2. Molecular and Functional Key Features and Oncogenic Drivers in Thymic Carcinomas;Cancers;2023-12-29

3. Thymic epithelial tumours: histopathological classification and differential diagnosis;Histopathology;2023-11-23

4. Genomic characterization of thymic epithelial tumors in a real-world dataset;ESMO Open;2023-10

5. STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines;Journal of Thoracic Oncology;2023-08